Picard Medical Inc. Common Stock (PMI)
Stock · AMEX · Health Care
$12.81as of 10/16/2026
Price chart
Active signals
About PMI
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company wa…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 75
- Website
- picardmedical.com
Fundamentals
- 1-day range
- $10$18.23
- Market cap
- $7.27M
- P/E (trailing)
- —
- P/E (forward)
- -2.22
- EPS (trailing)
- $-11.22
- Dividend yield
- —
- Beta
- -1.98
- Avg. volume
- 1.58M
How Picard Medical Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 30, 2026 · via SEC EDGAR / Finnhub
Picard Medical Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PMIPicard Medical Inc. Common Stock$12.75▲ 27.50%Market cap $7.27MP/E —$2.65$684
- NVNOenVVeno Medical Corporation Common Stock$7.47▼ 5.74%Market cap $6.93MP/E —$7.01$30.8
- SNOASonoma Pharmaceuticals Inc. Common Stock$1.12▼ 2.61%Market cap $5.99MP/E —$0.8501$4.25
- FEMYFemasys Inc. Common Stock$1.65▼ 4.90%Market cap $8.91MP/E —$1.67$22.2
- XAIRBeyond Air Inc. Common Stock$2.16▼ 2.26%Market cap $4.93MP/E —$2.31$55.6
- INBSIntelligent Bio Solutions Inc. Common Stock$1.5▲ 4.17%Market cap $4.76MP/E —$1.35$24.9
- CODXCo-Diagnostics Inc. Common Stock$0.654▼ 8.53%Market cap $9.91MP/E —$0.746$46.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PMI Picard Medical Inc. Common Stock | $7.27M | — | $12.75 | ▲ 27.50% | $2.65$684 |
| NVNO enVVeno Medical Corporation Common Stock | $6.93M | — | $7.47 | ▼ 5.74% | $7.01$30.8 |
| SNOA Sonoma Pharmaceuticals Inc. Common Stock | $5.99M | — | $1.12 | ▼ 2.61% | $0.8501$4.25 |
| FEMY Femasys Inc. Common Stock | $8.91M | — | $1.65 | ▼ 4.90% | $1.67$22.2 |
| XAIR Beyond Air Inc. Common Stock | $4.93M | — | $2.16 | ▼ 2.26% | $2.31$55.6 |
| INBS Intelligent Bio Solutions Inc. Common Stock | $4.76M | — | $1.5 | ▲ 4.17% | $1.35$24.9 |
| CODX Co-Diagnostics Inc. Common Stock | $9.91M | — | $0.654 | ▼ 8.53% | $0.746$46.5 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
India moves to ban nicotine pouches nationwide
The Indian government is seeking a nationwide crackdown on nicotine pouches due to health risks. This regulatory development is relevant to Picard Medical as it may impact the broader market for nicotine delivery products. The stock currently sits near its support level, reflecting the uncertainty surrounding this policy shift.
India moves to ban nicotine pouches nationwide. The Indian government is seeking a nationwide crackdown on nicotine pouches due to health risks. This regulatory development is relevant to Picard Medical as it may impact the broader market for nicotine delivery products. The stock currently sits near its support level, reflecting the uncertainty surrounding this policy shift.